Farhad Azimi

1.0k total citations · 1 hit paper
17 papers, 671 citations indexed

About

Farhad Azimi is a scholar working on Cancer Research, Oncology and Surgery. According to data from OpenAlex, Farhad Azimi has authored 17 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cancer Research, 7 papers in Oncology and 3 papers in Surgery. Recurrent topics in Farhad Azimi's work include Breast Cancer Treatment Studies (6 papers), Cancer Genomics and Diagnostics (4 papers) and Breast Lesions and Carcinomas (3 papers). Farhad Azimi is often cited by papers focused on Breast Cancer Treatment Studies (6 papers), Cancer Genomics and Diagnostics (4 papers) and Breast Lesions and Carcinomas (3 papers). Farhad Azimi collaborates with scholars based in Australia, United States and Germany. Farhad Azimi's co-authors include John F. Thompson, Richard A. Scolyer, Stanley W. McCarthy, Robyn P.M. Saw, Marc Moncrieff, Rajmohan Murali, Patrick J. Bryan, Carlo Pulitanò, Therese M. Becker and Michael Zhou and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Farhad Azimi

15 papers receiving 664 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor-Infiltrating Lymphocyte Grade Is an Independent Predictor of Sentinel Lymph Node Status and Survival in Patients With Cutaneous Melanoma

2012 606 citations Farhad Azimi, Richard A. Scolyer et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Farhad Azimi Australia	5	454	309	224	186	118	17	671
Teena Vithayathil United States	5	536 1.2×	299 1.0×	192 0.9×	228 1.2×	173 1.5×	5	763
Anne-Sophie Chrétien France	17	488 1.1×	417 1.3×	168 0.8×	101 0.5×	120 1.0×	42	806
Sterre T. Paijens Netherlands	7	440 1.0×	319 1.0×	168 0.8×	145 0.8×	120 1.0×	12	709
Catherine Schill Switzerland	4	676 1.5×	533 1.7×	166 0.7×	136 0.7×	74 0.6×	4	913
Sviatoslav M. Kendall United States	5	684 1.5×	445 1.4×	229 1.0×	236 1.3×	226 1.9×	6	966
Songyuan Gao China	3	469 1.0×	505 1.6×	339 1.5×	82 0.4×	133 1.1×	5	847
Tommaso D’Antuono Italy	14	358 0.8×	174 0.6×	187 0.8×	308 1.7×	164 1.4×	21	717
Sangeeta Kakoti Japan	7	500 1.1×	262 0.8×	243 1.1×	119 0.6×	67 0.6×	12	647
Annegé Vledder Netherlands	4	404 0.9×	307 1.0×	139 0.6×	126 0.7×	103 0.9×	9	626
Daniel A. Holterman United States	10	412 0.9×	235 0.8×	105 0.5×	169 0.9×	95 0.8×	12	631

Countries citing papers authored by Farhad Azimi

Since Specialization

Citations

This map shows the geographic impact of Farhad Azimi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farhad Azimi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farhad Azimi more than expected).

Fields of papers citing papers by Farhad Azimi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farhad Azimi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farhad Azimi. The network helps show where Farhad Azimi may publish in the future.

Co-authorship network of co-authors of Farhad Azimi

This figure shows the co-authorship network connecting the top 25 collaborators of Farhad Azimi. A scholar is included among the top collaborators of Farhad Azimi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farhad Azimi. Farhad Azimi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Azimi, Farhad, et al.. (2024). Evolution of Indocyanine Green Fluorescence in Breast and Axilla Surgery: An Australasian Experience. Life. 14(1). 135–135. 2 indexed citations

Hawes, Susan M., et al.. (2024). Dermatofibrosarcoma protuberans of the breast in pregnancy. Journal of Surgical Case Reports. 2024(1). rjad738–rjad738.

Zhou, Michael, et al.. (2024). Cost-Effectiveness of Radar Localisation Versus Wire Localisation for Wide Local Excision of Non-palpable Breast Cancer. Annals of Surgical Oncology. 31(6). 3916–3925. 4 indexed citations

Harris, Christopher, Farhad Azimi, Belinda Chan, et al.. (2024). Breast conservation versus mastectomy for metaplastic breast cancer: A systematic review and meta‐analysis. Asia-Pacific Journal of Clinical Oncology. 21(2). 150–155. 2 indexed citations

Zhou, Michael, et al.. (2023). Novel Dual Tracer Indocyanine Green and Radioisotope Versus Gold Standard Sentinel Lymph Node Biopsy in Breast Cancer: The GREENORBLUE Trial. Annals of Surgical Oncology. 30(11). 6520–6527. 18 indexed citations

Zhou, Michael, et al.. (2023). ASO Author Reflections: Indocyanine Green Fluorescence Sentinel Lymph Node Biopsy in Breast Cancer—An Alternative to Blue Dye?. Annals of Surgical Oncology. 30(11). 6528–6529. 1 indexed citations

Zhou, Michael, et al.. (2023). ASO Visual Abstract: Novel Dual Tracer Indocyanine Green and Radioisotope Versus Gold Standard Sentinel Lymph Node Biopsy in Breast Cancer—The GREENORBLUE Trial. Annals of Surgical Oncology. 30(11). 6530–6531. 1 indexed citations

Becker, Therese M., et al.. (2022). The management of hereditary melanoma, FAMMM syndrome and germline CDKN2A mutations: a narrative review. SHILAP Revista de lepidopterología. 5(2). 12–22. 2 indexed citations

Po, Joseph W., Yafeng Ma, Alison W. S. Luk, et al.. (2021). Single-Cell Analysis of BRAFV600E and NRASQ61R Mutation Status in Melanoma Cell Lines as Method Generation for Circulating Melanoma Cells. Methods in molecular biology. 2265. 277–286.

10.

Po, Joseph W., Yafeng Ma, Bavanthi Balakrishnar, et al.. (2021). PD-L1 Detection on Circulating Melanoma Cells. Methods in molecular biology. 2265. 223–233. 1 indexed citations

11.

Azimi, Farhad, et al.. (2020). Successful non-operative management of a traumatic thyroid haematoma in a goitrous gland. Trauma Case Reports. 30. 100386–100386. 2 indexed citations

12.

Po, Joseph W., Yafeng Ma, Daniel Brungs, et al.. (2019). Immunomagnetic isolation of circulating melanoma cells and detection of PD-L1 status. PLoS ONE. 14(2). e0211866–e0211866. 15 indexed citations

13.

Azimi, Farhad, Richard A. Scolyer, Marc Moncrieff, et al.. (2012). Tumor-Infiltrating Lymphocyte Grade Is an Independent Predictor of Sentinel Lymph Node Status and Survival in Patients With Cutaneous Melanoma. Journal of Clinical Oncology. 30(21). 2678–2683. 606 indexed citations breakdown →

14.

Azimi, Farhad, et al.. (1977). Calcification of the intrarenal branches of the renal arteries. Clinical Radiology. 28(2). 217–219. 3 indexed citations

15.

Azimi, Farhad, Jack Edeiken, & G. Dean MacEwen. (1974). Larsen's Syndrome Congenital Dislocation Of Multiple Large Joints Of The Extremities Associated With An Unusual Flat Fades. Australasian Radiology. 18(3). 333–335. 2 indexed citations

16.

Azimi, Farhad & Patrick J. Bryan. (1974). Weismann-Netter-Stuhl syndrome (Toxopachyostéose diaphysaire tibio-péronière). British Journal of Radiology. 47(561). 618–620. 7 indexed citations

17.

Azimi, Farhad & Patrick J. Bryan. (1974). Familial occurrence of renal pseudotumour due to enlarged column of bertin in two brothers and their first cousin. Clinical Radiology. 25(4). 467–470. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact